India Solidifies Position as Most Attractive Global CDMO Destination: LoEstro Report
May 13, 2025
New Delhi [India], May 13: India is poised to lead the global biopharma outsourcing landscape, leveraging recent regulatory shifts to cement its status as the most attractive destination for CDMO services. According to a new report by LoEstro Advisors, the country's Contract Development and Manufacturing Organisation (CDMO) industry is projected to reach USD 14 billion by FY28, growing at a rapid 14% CAGR. This positions India not just as a major player, but also as a global front-runner in drug development and manufacturing services.
Read More ..
